P

Inventor

ZHANG XUQING

US45 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG XUQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

26 patents
US9067898B1Jun 30, 2015

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV13 citations84
US7696239B2Apr 13, 2010

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

JANSSEN PHARMACEUTICA NV9 citations84
US7338973B2Mar 4, 2008

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

JANSSEN PHARMACEUTICA NV11 citations84
US7288553B2Oct 30, 2007

Indole derivatives as selective androgen receptor modulator (SARMS)

JANSSEN PHARMACEUTICA NV14 citations84
US7282507B2Oct 16, 2007

Indole derivatives as selective androgen receptor modulators (SARMS)

JANSSEN PHARMACEUTICA NV11 citations84
US7812183B2Oct 12, 2010

Benzopyran derivatives as potassium channel openers

JANSSEN PHARMACEUTICA NV3 citations63
US7759498B2Jul 20, 2010

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

JANSSEN PHARMACEUTICA NV4 citations63
US7465809B2Dec 16, 2008

Heterocycle derivatives useful as selective androgen receptor modulators (SARMs)

JANSSEN PHARMACEUTICA NV4 citations63
US7427682B2Sep 23, 2008

Indole derivatives as selective androgen receptor modulators (SARMS)

JANSSEN PHARMACEUTICA NV3 citations62
US10618893B2Apr 14, 2020

GPR120 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US10118922B2Nov 6, 2018

GPR120 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US9434688B2Sep 6, 2016

Indole derivatives as selective androgen receptor modulators (SARMS)

JANSSEN PHARMACEUTICA NV0 citations52
US9303037B2Apr 5, 2016

Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators

JANSSEN PHARMACEUTICA NV0 citations52
US8053441B2Nov 8, 2011

Pyrazolylquinazolinones as potassium channel openers

JANSSEN PHARMACEUTICA NV0 citations52
US7838553B2Nov 23, 2010

Benzopyran derivatives as potassium channel openers

JANSSEN PHARMACEUTICA NV0 citations52
US7705147B2Apr 27, 2010

Indole derivatives as selective androgen receptor modulators (SARMS)

JANSSEN PHARMACEUTICA NV0 citations52
US7678926B2Mar 16, 2010

Indole derivatives as selective androgen receptor modulators (SARMS)

JANSSEN PHARMACEUTICA NV0 citations52
US7674793B2Mar 9, 2010

Tricyclic dihydropyrazines as potassium channel openers

JANSSEN PHARMACEUTICA NV0 citations52
US7626036B2Dec 1, 2009

Bicyclic heterocycles useful as selective androgen receptor modulators

JANSSEN PHARMACEUTICA NV0 citations52
US7452914B2Nov 18, 2008

Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors

JANSSEN PHARMACEUTICA NV1 citations52
US9771375B2Sep 26, 2017

Indazole compounds useful as ketohexokinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10590083B2Mar 17, 2020

Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US10399944B2Sep 3, 2019

Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US10336701B2Jul 2, 2019

Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists

JANSSEN PHARMACEUTICA NV0 citations42
US10077241B2Sep 18, 2018

Tetrahydro-benzoimidazolyl modulators of TGR5

JANSSEN PHARMACEUTICA NV0 citations42
US7655683B2Feb 2, 2010

Imidazolopyrazole derivatives useful as selective androgen receptor modulators

JANSSEN PHARMACEUTICA NV0 citations42

ZHANG XUQING

8 patents

LANTER JAMES C

3 patents

ORTHO MCNEIL PHARM INC

2 patents

SUI ZHIHUA

2 patents

MICROSOFT TECHNOLOGY LICENSING LLC

2 patents

RUBIUS THERAPEUTICS INC

1 patent

J & J PHARMACEUTICAL RES & DEV

1 patent